A carregar...
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a very rare and highly aggressive cancer of the pleura associated in most cases with asbestos exposure. To date, no really efficient treatments are available for this pathology. Recently, it has been shown that epigenetic drugs, particularly DNA me...
Na minha lista:
| Publicado no: | Clin Epigenetics |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006850/ https://ncbi.nlm.nih.gov/pubmed/29946373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0517-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|